Moderna vaccine trial pleases investors, EBIT...

Meta and Microsoft reported quarterly earnings as investors raised concerns about AI spending, and the US Federal Reserve held interest rates steady. The Bank of Japan is also expected to leave rates unchanged at its meeting on Friday, and UK oil and gas companies are looking awa ...  Show more

Ukraine is shifting its long-range drone campaign to focus on critical Russian infrastructure, and Big Tech companies are facing an AI dilemma as they report quarterly earnings. Plus, Google DeepMind is leaving behind its Nobel-winning AlphaFold project for new ventures, and PwC ...  Show more

There’s more positive news on the vaccine front, companies are raising dividends, and earnings guidance has been strong. Corporate America seems to think we’ve gotten past the worst effects of the pandemic, but have we?

Plus Bitcoin nearing the $19,000 mark after surging ...

Carl Quintanilla, Jim Cramer and David Faber discuss China’s property market crisis and the Federal Reserve's decision to keep current monetary stimulus in place for just a little bit longer. The Food and Drug Administration has authorized Pfizer and BioNTech’s Covid-19 booster s ...  Show more

Carl Quintanilla, Jim Cramer and David Faber discuss the surge in stocks. Markets getting a boost from blowout results from Goldman Sachs and Moderna’s vaccine news. Goldman Sachs crushing earnings estimates its biggest outperformance in nearly a decade. Revenue was more than ...

Chinese officials’ pledges to provide bolder support for economic growth are fuelling a rally in shares related to Chinese consumption, Chinese real estate, and Asian mining stocks. China beneficiaries in Europe also posted strong gains yesterday. Meanwhile, US equity markets ...